Literature DB >> 9536566

Management of thyrotoxicosis in pregnancy.

A Ghaneim1, P Atkins.   

Abstract

Between April 1985 and June 1995, 20 patients being treated for thyrotoxicosis became pregnant. These patients are reviewed. Control of thyrotoxicosis early in pregnancy using minimal doses of propylthiouracil or carbimazole, followed by subtotal thyroidectomy in the middle trimester, is safe for both mother and fetus.

Entities:  

Mesh:

Year:  1998        PMID: 9536566

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

Review 1.  Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.

Authors:  P Atkins; S B Cohen; B J Phillips
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

2.  Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study.

Authors:  Hila Rosenfeld; Asher Ornoy; Svetlana Shechtman; Orna Diav-Citrin
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

3.  Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.

Authors:  F M Finucane; J O'Connell; B T Kinsley
Journal:  Ir J Med Sci       Date:  2007-07-05       Impact factor: 1.568

4.  Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.

Authors:  Yoon-Young Cho; Ho Sang Shon; Hyun Dae Yoon
Journal:  Korean J Intern Med       Date:  2005-12       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.